Clinical Trials Logo

Clinical Trial Summary

The goal of this observational study is to test the Evaluation of the efficacy and mechanism of action about Huang-long Zhi-xiao Granule to improve the control rate of Asthma chronic duration. The main questions it aims to answer are: - [Relying on the top-level experimental design, scientifically evaluated the efficacy and safety of Huang-long Zhi-xiao Granule in patients with chronic asthma (hot asthma), and provided evidence support for the clinical application of Classical Prescriptions.] - [Through the retained sample to test Asthma-related inflammatory indicators, immunoglobulins, T cell subsets, etc. To investigate the mechanism of action of Huang-long Zhi-xiao Granule in patients with chronic duration of asthma (hot asthma).]


Clinical Trial Description

Bronchial asthma attacks are erratic and difficult to heal, which seriously affects the quality of life of patients, and their physical and mental health is also seriously affected by asthma. This study will conduct clinical observations in patients with chronic persistence (hot wheezing) of bronchial asthma, scientifically evaluate the efficacy and safety of Huanglong Anti-Wheezing in patients with asthma chronic duration (hot wheezing), and provide evidence support for the clinical application of Huanglong Anti-Wheezing Formula. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05841901
Study type Interventional
Source Henan University of Traditional Chinese Medicine
Contact Minghang Wang, MD
Phone 0371-66248624
Email wmh107hn@163.com
Status Not yet recruiting
Phase N/A
Start date June 1, 2023
Completion date December 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04438408 - National Survey on Care Pathway and Quality of Life in Patients With Severe Asthma According to Their Phenotype.
Recruiting NCT04693975 - Social Distancing During the COVID-19 Pandemic and People Living With Chronic Respiratory Diseases
Completed NCT04456270 - Asthma Control in a Dutch Primary Care Population
Active, not recruiting NCT04593394 - Inducible Laryngeal Obstruction in Severe Asthma in Severe Asthma
Not yet recruiting NCT06364527 - Use of Aptar Digital Health's Respiratory Disease Management Platform for Asthma N/A
Not yet recruiting NCT03879590 - Efficacy Of Doxophylline As A Sparing Treatment For Inhaled Corticosteroids In Mexican Children With Asthma Phase 3
Recruiting NCT04613245 - Health-Related Quality of Life of Patients With Asthma During the Pandemic of COVID-19
Withdrawn NCT05304494 - Sentinel - Triaging Acute Breathlessness Using Multi-Modal Biomarkers
Completed NCT03498742 - Asthmatic Subjects Could Live Without Short Acting beta2 Agonists
Recruiting NCT05572177 - Feasibility of a Smartphone Application for Asthma Self-management N/A
Not yet recruiting NCT04799678 - Pilot Voice Sample Collection From People With Asthma
Not yet recruiting NCT06273072 - Metformin IN Asthma for Overweight and Obese Individuals (MINA) Phase 2
Terminated NCT03736629 - Azithromycin Treatment for the Airway Microbiome in Asthma Phase 2
Recruiting NCT03788057 - Inflammatory Indices in Predicting the Failure of Inhaled Corticosteroids Reduction in Young Participants With Asthma N/A
Not yet recruiting NCT02283008 - Inhaler Technique Training N/A
Completed NCT02227394 - Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients Phase 2
Not yet recruiting NCT05432440 - Evaluation of Pharmacist-guided Digital-based Asthma Education for Indonesian Children With Asthma N/A
Completed NCT05270278 - Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy
Completed NCT03642418 - User-Friendly Spirometer and Mobile App for Self-Management and Home Monitoring of Asthma Patients
Recruiting NCT05609760 - Pictograms to Facilitate Comprehension of Medical Indications N/A